Trials / Completed
CompletedNCT03141385
Renal Effects of RIPC in Patients After Total Arch Replacement
Renal Effects of Remote Ischemic Preconditioning in Patients After Total Arch Replacement
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the hypothesis that remote ischemic preconditioning prevents acute kidney injury and improves clinical outcomes in patients undergoing total arch replacement.
Detailed description
Acute kidney injury (AKI) is a well-recognized complication after cardio-thoracic surgeries and is associated with increased morbidity and mortality. Total arch replacement is reported with a relatively high incidence of post-operative AKI. In addition, few effective preventive or therapeutic interventions for AKI have been identified. A number of studies have now addressed renal protection as a primary outcome following RIPC. Because the mechanism of I/R injury are similar to those proposed for AKI after CPB, the purpose of this study is to test the hypothesis that remote ischemic preconditioning prevents acute kidney injury and improves clinical outcomes in patients undergoing total arch replacement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | remote ischemic preconditioning | Remote ischemic preconditioning (RIPC) will be induced after the general anesthesia prior to the cardiopulmonary bypass by four cycles of right limber ischemia (5-min blood pressure cuff inflation to a pressure of 200mmHg or a pressure that is 50 mmHg higher than SAP and 5-min cuff deflation) |
| OTHER | Control | Four cycles of right upper limb pseudo ischemia and reperfusion, which will be induced by 5-minute blood pressure cuff inflation to a low pressure of 20 mmHg followed by 5-minute cuff deflated. |
Timeline
- Start date
- 2017-04-07
- Primary completion
- 2018-05-01
- Completion
- 2018-05-30
- First posted
- 2017-05-05
- Last updated
- 2018-07-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03141385. Inclusion in this directory is not an endorsement.